| 1 |
Spatial and temporal control of chemical processes
Sidonie Aubert, Marine Bézagu, Alan C. Spivey et al. · Nature Reviews Chemistry
Review |
24 Oct 2019 |
119 |
| 2 |
EndoC-βH5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion
Bruno Blanchi et al. · Molecular Metabolism
Open access |
11 Jul 2023 |
46 |
| 3 |
BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study
Tim Heise, Grégory Meiffren, Bertrand Alluis et al. · Diabetes Obesity and Metabolism
|
19 Dec 2018 |
42 |
| 4 |
Nanoparticulate Impurities in Pharmaceutical-Grade Sugars and their Interference with Light Scattering-Based Analysis of Protein Formulations
Daniel Weinbuch, Jason K. Cheung, Jurgen Ketelaars et al. · Pharmaceutical Research
Open access |
28 Jan 2015 |
41 |
| 5 |
Ultra‐rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14‐day crossover treatment study in people with type 1 diabetes
Grit Andersen, Grégory Meiffren, Daniela Lamers et al. · Diabetes Obesity and Metabolism
Open access |
20 Jun 2018 |
39 |
| 6 |
ADO09, a co‐formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes
Grit Andersen, Grégory Meiffren, Susanne Famulla et al. · Diabetes Obesity and Metabolism
Open access |
18 Dec 2020 |
28 |
| 7 |
Carbamino group formation with peptides and proteins studied by mass spectrometry
Péran Terrier, Don J. Douglas · Journal of the American Society for Mass Spectrometry
|
2 Jun 2010 |
13 |
| 8 |
Mass Spectra and Ion Collision Cross Sections of Hemoglobin
Kang Yang, Péran Terrier, Donald J. Douglas · Journal of the American Society for Mass Spectrometry
|
27 Jan 2011 |
13 |
| 9 |
A co‐formulation of pramlintide and insulin A21G ( ADO09 ) improves postprandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes
Grit Andersen, Rosy Eloy, Susanne Famulla et al. · Diabetes Obesity and Metabolism
|
12 Jan 2023 |
11 |
| 10 |
Solution and Gas-Phase H/D Exchange of Protein–Small-Molecule Complexes: Cex and Its Inhibitors
Yang Kang, Péran Terrier, Chuan‐Fan Ding et al. · Journal of the American Society for Mass Spectrometry
|
17 Oct 2011 |
10 |
| 11 |
Better glycaemic control with BioChaperone glargine lispro co‐formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetes
Grégory Meiffren, Theresa Herbrand, Ernestos Anastassiadis et al. · Diabetes Obesity and Metabolism
Open access |
4 Mar 2019 |
8 |
| 12 |
Diffusion of rigid nanoparticles in crowded polymer-network hydrogels: dominance of segmental density over crosslinking density
Stefan Walta, Fany Di Lorenzo, Kai Ma et al. · Colloid & Polymer Science
|
11 Apr 2017 |
8 |
| 13 |
ADO09, a co‐formulation of pramlintide and insulin A21G, lowers body weight versus insulin lispro in type 1 diabetes
Grit Andersen, Rosy Eloy, Tim Heise et al. · Diabetes Obesity and Metabolism
Open access |
7 Aug 2024 |
4 |
| 14 |
03-6: ADOSHELL®, A NON-FIBROTIC ENCAPSULATION SYSTEM FOR HUMAN ISLET TRANSPLANTATION WITHOUT IMMUNOSUPPRESSION
Ouardane Jouannot, Alexandre Martin, J Brun et al. · Transplantation
|
Jun 2025 |
0 |
| 15 |
AdoShell®, a non-fibrotic encapsulation system for cell delivery
Ouardane Jouannot, J.-F. Brun, Clément Cocita et al. · Cytotherapy
|
30 Apr 2025 |
0 |
| 16 |
328.4: How to deliver a therapeutic dose of encapsulated human islets?
Rosy Eloy, Ouardane Jouannot, Alexandre Geissler et al. · Transplantation
|
Oct 2023 |
0 |
| 17 |
Ultra-rapid BioChaperone Lispro ameliorates postprandial blood glucose (PPBG) in a group with diabetes mellitus
Grit Andersen, Grégory Meiffren, Bertrand Alluis et al. · Diabetologie und Stoffwechsel
|
5 May 2017 |
0 |